Recent Finacing
Recent Raise
Gadeta is a Utrecht biotech developing TEG therapies using combinatorial TCR exchange to express high-affinity γδ TCRs on αβ T cells, targeting metabolic vulnerabilities in hematologic and solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors